4(5)-phenylimidazole has been researched along with indoximod in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, D; Li, Y | 1 |
| Liu, HM; Tang, K; Wang, B; Yu, B | 1 |
1 review(s) available for 4(5)-phenylimidazole and indoximod
| Article | Year |
|---|---|
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors and PROTAC-based degraders for cancer therapy.
Topics: Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Molecular Structure; Neoplasms; Proteolysis; Small Molecule Libraries | 2022 |
1 other study(ies) available for 4(5)-phenylimidazole and indoximod
| Article | Year |
|---|---|
Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
Topics: Binding Sites; Cell Membrane Permeability; Enzyme Inhibitors; Half-Life; HeLa Cells; Humans; Indans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inhibitory Concentration 50; Microsomes, Liver; Molecular Docking Simulation; Protein Structure, Tertiary; Structure-Activity Relationship; Surface Plasmon Resonance | 2017 |